drugset / Trial / NCT06439563
Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The sutdy aims to to demonstrate the non-inferiority of JP-1366 10 mg compared to Lanston Capsule 15 mg in preventing NSAIDs-induced peptic ulcers and to compare/evaluate the efficacy and safety of JP-1366 10 mg.
Timeline
- Start
- 2024-10-22
- Primary completion
- 2027-08
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JP-1366 | Unknown | 10 mg | Oral |
| Comparator | Lanston | Unknown | 15 mg | Oral |